Global Trade Alert
Global Trade Alert

Back to state act

United States of America: BARDA awards USD 32 million to DiaSorin Molecular LLC for the FDA clearance of a combined SARS-CoV-2 and influenza A and B test on a point-of-care platform

Description

On 28 September 2022, Biomedical Advanced Research and Development Authority (BARDA) announced providing USD 31 million in funding to DiaSorin Molecular LLC. The stated objective is to help the compan...

Sign in to see full description

Intervention Details

Intervention Type

State aid, unspecified

MAST Chapter

L: Subsidies (excl. export subsidies)

Implementation date

28 Sep 2022

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 1 products

Threads

See all

This intervention is not part of any Thread yet.